Elixxer Ltd.

Overview

Elixxer Ltd. is a Canadian investment company specializing in the cannabis sector. The company focuses on providing shareholders with exposure to a diverse range of businesses, products, and services within the legal global cannabis market. Elixxer Ltd. aims to build a vertically integrated system of interconnected legal cannabis companies, encompassing cultivation, processing, and distribution across various regions. The company's investment strategy includes targeting early-stage to growth-stage companies, with investments ranging from seed funding to buyouts and distressed assets. Elixxer Ltd. has a geographical focus on North America, Europe, and Australia, with investments in countries such as Canada, the United States, Australia, Jamaica, Switzerland, and Italy. The firm operates across multiple industries, including cannabis, healthcare, consumer products, pharmaceuticals, agriculture, biotechnology, medical devices, wellness, food and beverage, pet care, cosmetics, vaping, real estate, technology, and media. Elixxer Ltd. has a history of increasing its ownership in key investments, such as raising its stake in Little Green Pharma, an Australian licensed medical cannabis producer, from 14.1% to 40.4%. The company has also been involved in the first commercial sales of medical cannabis in Jamaica through its partner Global Canna Labs. Elixxer Ltd. continues to seek opportunities to invest in legally compliant medicinal cannabis companies globally, aiming to expand its portfolio and impact in the rapidly growing cannabis industry.

Investment Focus

• Legally compliant medicinal cannabis companies
• Companies with a focus on cultivation, processing, and distribution
• Businesses operating in regions with favorable regulatory environments for cannabis investment

Portfolio Companies